InvestorsHub Logo
Followers 28
Posts 2777
Boards Moderated 0
Alias Born 03/24/2019

Re: None

Monday, 06/12/2023 10:34:22 AM

Monday, June 12, 2023 10:34:22 AM

Post# of 36577
News / announcements could drop any day. We would think that potential deals involving Revive's (patented) "Bucillamine" are being discussed in parallel with the FDA process. Plus we should remember that Bucillamine is not only a potential treatment for Covid symptoms but also proven to be very effective for Rheumatoid Arthritis for example. If the FDA does not swing our way for a Covid treatment after all, this whole process has at least significantly increased exposure for, and the knowledge of, Bucillamine on the big stage.